Dr. Steven Kahn, professor (Metabolism, Endocrinology and Nutrition) is co-author of “Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial” in JAMA.
Dr. Steven Kahn, professor (Metabolism, Endocrinology and Nutrition) is co-author of “Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial” in JAMA.